Hepatiotis C and Pegylated Interferon Bakcground

Background on Hepatits C from the World Health Organization

The Hepatitis C virus (HCV) is a major cause of acute hepatitis and chronic liver disease, including cirrhosis2 and liver cancer. Globally, an estimated 170 million persons are chronically infected with HCV and 3 to 4 million persons are newly infected each year. HCV is spread primarily by direct contact with human blood. The major causes of HCV infection worldwide are use of unscreened blood transfusions, and re-use of needles and syringes that have not been adequately sterilized.

Background on Pegylated Interferon from the AIDS Treatment Data Network

This pamphlet provides a brief description of the drug, how it is used, its side effects, and other practical information.

Hepatitis C Among Injecting Drug Users in the New EU Member States and Nieghboring Countries

This report by the Central and Eastern European Harm Reduction Network explains the high prevalence of HCV among intravenous drug users (IDUs) and discusses prevention and treatment strategies for IDUs

iBase Guide to hepatitis c for people living with HIV 

This guide provides information for people infected with both HCV and HIV.  It focusses on answering questions regarding transmission, treatment, and the health risks associated with both diseases.

Management of Hepatitis C and HIV Coinfection Clinical Protocol for the WHO European Region

These are protocol by the World Health Organization for the diagnosis and treatment of HCV.